Suppr超能文献

减少或停用抗精神病药物治疗智障成人的攻击性行为:一项系统评价

Reduction or discontinuation of antipsychotics for challenging behaviour in adults with intellectual disability: a systematic review.

作者信息

Sheehan Rory, Hassiotis Angela

机构信息

Division of Psychiatry, University College London, London, UK.

Division of Psychiatry, University College London, London, UK.

出版信息

Lancet Psychiatry. 2017 Mar;4(3):238-256. doi: 10.1016/S2215-0366(16)30191-2. Epub 2016 Nov 10.

Abstract

The use of antipsychotics to manage challenging behaviour in adults with intellectual disability is widespread but controversial, and evidence is scarce. There is a perception that antipsychotics used in this context can be reduced or discontinued, and this has been a major focus of recent national policy. However, such an intervention risks harm as well as having potential benefits. We reviewed the available evidence and found that antipsychotics can be reduced or discontinued in a substantial proportion of adults who use them for challenging behaviour, although not always without adverse effects. There is a group which displays behavioural deterioration on antipsychotic reduction that prevents discontinuation; predictors of poor response could not be reliably identified. In view of the relatively scarce data and methodological limitations of the available studies, we cannot draw firm conclusions to inform a population level approach to this issue. Antipsychotic medication used for behaviour should be reviewed regularly and an individualised approach taken to treatment.

摘要

使用抗精神病药物来管理成年智障患者的挑战性行为十分普遍,但存在争议,且证据稀少。有一种观点认为,在此背景下使用的抗精神病药物可以减量或停用,这已成为近期国家政策的一个主要关注点。然而,这种干预既存在潜在益处,也有造成伤害的风险。我们回顾了现有证据,发现相当一部分将抗精神病药物用于应对挑战性行为的成年人可以减量或停用这些药物,尽管并非总是没有不良反应。有一部分人在减少抗精神病药物用量时会出现行为恶化,从而无法停药;目前尚无法可靠地确定反应不佳的预测因素。鉴于现有研究的数据相对稀少且存在方法学上的局限性,我们无法得出确凿结论,为针对这一问题的人群层面方法提供依据。用于行为管理的抗精神病药物应定期进行评估,并采取个体化的治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验